Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-24 @ 11:00 PM
NCT ID:
NCT01077869
Eligibility Criteria:
Inclusion Criteria:
* Non-operated histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx (except the posterior wall) and lymph node metastases from the unknown primary tumor (CUP)
* Stage T1-4; Tx N+ for the CUP
* Multidisciplinary Group of Head and Neck Tumors at Ghent University Hospital decision of radical radiotherapy (±concurrent chemotherapy)
* Informed consent obtained, signed and dated before specific protocol procedures.
Exclusion Criteria:
* Age \< 18 years
* Pregnant or lactating women
* Active infection or fistula in the oral/oropharyngeal mucosa
* Previous cancer of the oral cavity and the oropharynx
* Prior head-and-neck radiotherapy
* Expectation of non-compliance with the study protocol
* Known allergy for topical anesthetics (Xylocaïne)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01077869
Study Brief:
Protocol Section:
NCT01077869